Bradley Merrill Thompson, Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in multiple publications on the topic of the FDA’s drafted regulatory guidelines on clinical decision support, in his work with the CDS Coalition.

Following is an excerpt from MobiHealthNews, “Clinical Decision Support Coalition Letter Criticizes FDA’s Stance on CDS,” by Laura Lovett.

Yesterday the Clinical Decision Support (CDS) Coalition released a comment broadly criticizing the FDA’s recent CDS draft guidance, noting that the draft would expand the scope of FDA regulations, and that it fails to take a risk-based approach, lumping in many low-risk programs already on the market.

“The resulting overregulation would be to the detriment of patient care,” CDS Coalition Leader Bradley Merrill Thompson wrote in the comment that he penned on behalf of the organization.

The Clinical Decision Support Coalition is a recently-founded organization dedicated to ensuring clinical decision making software doesn’t become overregulated, while ensuring patient safety.

In December the FDA finally released the new CDS draft guidance, which outlined forms of CDS which won’t be regulated based on the degree of human involvement instead of based on risk. The draft says CDS software won’t be regulated if the physician can independently review and understand the basis of the software’s decision.

The coalition’s letter outlines three changes that it recommends to the CDS draft. First, it says the FDA should exempt low risk CDS software from FDA oversight and use the international criteria for stratifying risk of CDS software. Secondly, the organization urged the FDA to modify the draft to follow the Cures Act, which “allows for unregulated software that provides unique insights that the healthcare professional might not have come up with on his or her own, as long as the user has access to the factual basis for the insights.” Lastly, the organization said the FDA should include more examples of what is and isn’t going to be regulated.

Related reading:

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.